MedPath
HSA Approval

PEMETREXED POWDER FOR SOLUTION FOR INFUSION 500mg/vial

SIN14536P

PEMETREXED POWDER FOR SOLUTION FOR INFUSION 500mg/vial

PEMETREXED POWDER FOR SOLUTION FOR INFUSION 500mg/vial

April 10, 2014

MYLAN PHARMACEUTICALS PTE. LTD.

MYLAN PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMYLAN PHARMACEUTICALS PTE. LTD.
Licence HolderMYLAN PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

L01BA04

pemetrexed

Manufacturer Information

mylan pharmaceuticals pte. ltd.

Mylan Laboratories Limited [OTL]

Active Ingredients

Pemetrexed disodium 551.424mg eqv Pemetrexed

500mg

Pemetrexed

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PEMETREXED POWDER FOR SOLUTION FOR INFUSION 500mg/vial - HSA Approval | MedPath